Usher Syndrome Market, By Type (Usher Syndrome Type II, Usher Syndrome Type I, and Usher Syndrome Type III), By Diagnosis (Genetic Testing, Electroretinogram (ERG), Optical Coherence Tomography (OCT), Videonystagmography, Audiological Testing, and Others (e.g., Clinical Evaluation, Imaging Tools)), By Treatment (Gene Therapy, Cochlear Implants and Hearing Aids, Retinal Implants and Vision Aids, Rehabilitation and Assistive Devices, and Supportive Therapies (Speech, Physical, Occupational)), By Patient Age Group (Pediatric and Adult), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacies), By End User (Hospitals and Clinics, Specialty Centers (ENT, Ophthalmology, Genetic), Homecare Settings, and Others (Research and Academic Institutes)), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)